Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

396

HTML

2566

Figures (1-2)

209

Tables (1-5)

197

Sum=3368

Feb 7, 2006 (publication date) through Dec 11, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 7, 2006; 12(5): 739-746
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739

Table 3 Correlation of microproteinuria and creatinine clearance of IBD patients after 5-ASA treatment (mean±SE)

	Ulcerative colitis (n=194)5-ASA treatment		P	Crohn's disease (n=83)5-ASA treatment		P
	No (n=37)	Yes (n=157)		No (n=15)	Yes (n=68)	P
Urine m-ALB (μg/min)	8.99 ± 2.10	9.90 ± 1.29	P	0.794	8.08 ± 2.57	7.13 ± 1.08	0.562
Urine β₂mGLB (μg/min)	163 ± 61.16	107 ± 12.07	0.852	274 ± 129.2	111.0 ± 20.15	0.083
Urine β-NAG (U/L)	4.22 ± 0.82	2.67 ± 0.18	0.118	2.79 ± 0.91	2.42 ± 0.26	0.845
Urine Kcr (mL/min)	117 ± 7.25	119 ± 3.11	0.987	130 ± 7.62	129 ± 4.05	0.713

Citation: Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.739